Michael McCaughan
As one of his duties resulting from the FDA Amendments Act, Division of Drug Marketing Advertising & Communications Director Tom Abrams needs to define "clear, conspicuous and neutral" in the...
Clarifying "Clear, Conspicuous and Neutral": Advertisers Will Learn New DTC Standard on the Fly
FDA's new pre-review program for direct-to-consumer ads is up and running. The agency also has a working definition for the new standard governing risk information in broadcast ads: present it the same way you do the benefits.